cIAI

Tetraphase Pharma’s Antibiotic Wins FDA Approval for Gut Infections
Xconomy
Mon, 08/27/18 - 11:04 pm
Tetraphase Pharmaceuticals
Xerava
FDA
antibiotics
cIAI
complicated intra-abdominal infections